Evidence map›Paper›PMID 20026624›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2010

Blood glucose test strips: options to reduce usage.

Tara Gomes, David N Juurlink, Baiju R Shah, J Michael Paterson, Muhammad M Mamdani

Open access · goldAbstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2011
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The impact of policies to reduce blood glucose test strip utilization and costs in Canada.Canadian journal of public health = Revue canadienne de sante publique · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Blood glucose meter market: this world is undergoing drastic changes.Journal of diabetes science and technology · 2013
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tara GomesInstitute for Clinical Evaluative Sciences, Toronto, Ont.
David N Juurlink
Baiju R Shah
J Michael Paterson
Muhammad M Mamdani
Institute for Clinical Evaluative Sciences · CASt. Michael's Hospital · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundRecent evidence suggests that, despite widespread use, self-monitoring of blood glucose levels has little clinical benefit in many patients with diabetes. The impact of more focused public-payer policies for the use of blood glucose test strips may be substantial.

methodsWe conducted a cross-sectional analysis of annual prescription claims for test strips between 1997 and 2008 for patients in Ontario aged 65 and older with diabetes. Patients were stratified into 1 of 4 hierarchical groups according to the most intensive glucose-lowering treatment received during each calendar year. Test strip use was calculated annually for each group over the study period, and the effects of 5 hypothetical policy scenarios of more selective test strip use were assessed.

resultsTest strip use increased by almost 250% from 1997 to 2008, with 52.6% (n = 263,513) of included patients receiving a prescription during 2008. Almost half of these patients were at low risk for drug-induced hypoglycemia. In 2008, over 117 million test strips were dispensed in Ontario; however, more focused policy scenarios could have reduced this number by between 9.5 million and 74.5 million test strips.

interpretationMany people who self-monitor their blood glucose are at relatively low risk for drug-induced hypoglycemia. The economic benefits associated with more selective testing could be redirected to more effective interventions for patients with diabetes.

Indexed as

Health ExpendituresBlood Glucose Self-MonitoringCross-Sectional StudiesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HumansInsurance, Pharmaceutical ServicesMiddle AgedOntario

Identifiers

PMID20026624
PMCPMC2802602
OpenAlexW2138759282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.